In 2020, the SEC issued new guidance on MD&A in light of COVID-19. The authors of this Securities & Commodities Regulation article discuss this guidance in detail, as well as recent amendments to Item 303 of Regulation S-K, and guidance on key performance indicators. They then turn to discussions of disclosure obligations relating to cybersecurity
Christine M. McDevitt
2021 SEC Filing Deadlines and Financial Statement Staleness Dates
This Legal Update summarizes the US Securities and Exchange Commission’s 2021 calendar year filing deadlines and financial statement staleness dates.
Nasdaq Files Rule Proposal with SEC for Board Diversity and Disclosure Requirement
On December 1, 2020, the Nasdaq Stock Market LLC filed with the US Securities and Exchange Commission (SEC) a proposal for new listing rules related to board diversity and disclosure, which are intended to advance board diversity and enhance the transparency and comparability of diversity statistics. The new rules would require Nasdaq-listed companies:
- to have,
…
SEC Amends Shareholder Proposal Rule
On September 23, 2020, the US Securities and Exchange Commission adopted amendments to Rule 14a-8 promulgated under the Securities Exchange Act of 1934. The amendments will generally be effective for shareholders’ meetings to be held on or after January 1, 2022. This Legal Update provides background and details on the amendments and notes practical considerations…
SEC Amends Rule 14a-8
On September 23, 2020, the Securities and Exchange Commission adopted amendments to Exchange Act Rule 14a-8, the shareholder-proposal rule, which we summarize below.
Ownership threshold for submission. The amendments create a range of the amount of a company’s securities required to be held in order to submit a shareholder proposal, permitting shareholders to submit a…